This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
This threat actor has been active since at least 2009, possibly as early as 2007, and it was involved in both cyber espionage campaigns and sabotage activities aimed to destroy data and disrupt systems. The attacks aimed at a Ministry of Health and a pharmaceutical company involved in the development of the COVID-19 vaccine.
The Winnti group was first spotted by Kaspersky in 2013, but according to the researchers the gang has been active since 2007. The APT group targeted organizations in various industries, including the aviation, gaming, pharmaceuticals, technology, telecoms, and software development industries.
The Winnti group was first spotted by Kaspersky in 2013, but according to the researchers the gang has been active since 2007. The APT group targeted organizations in various industries, including the aviation, gaming, pharmaceuticals, technology, telecoms, and software development industries. a South Korean video game company.”
Prior to that, akafitis@gmail.com was used as the email address for the account “ Fitis ,” which was active on Exploit between September 2006 and May 2007. ru in its early years, but for a brief period in 2007 it appears this website was inadvertently exposing all of its file directories to the Internet. ru in 2008.
The APT28 group (aka Fancy Bear , Pawn Storm , Sofacy Group , Sednit , and STRONTIUM ) has been active since at least 2007 and it has targeted governments, militaries, and security organizations worldwide. The group was involved also in the string of attacks that targeted 2016 Presidential election.
Recently Chronicle researchers while investigating the cyber attack that hit the Bayer pharmaceutical company in April spotted a Linux variant of the Winnti backdoor. The Winnti group was first spotted by Kaspersky in 2013, according to the researchers the gang has been active since 2007.
The Winnti group was first spotted by Kaspersky in 2013, but according to the researchers the gang has been active since 2007. The APT group targeted organizations in various industries, including the aviation, gaming, pharmaceuticals, technology, telecoms, and software development industries.
The Winnti group was first spotted by Kaspersky in 2013, but according to the researchers the gang has been active since 2007. The APT group targeted organizations in various industries, including the aviation, gaming, pharmaceuticals, technology, telecoms, and software development industries.
Tuesday, 21 August 2007 Janssen-Cilag Wiki Case Study Here is a great Aussie wiki case study shared by Nathan Wallace from Janssen-Cilag , a pharmaceutical subsidiary of Johnson & Johnson. Disclaimer: Information on this blog is of a general nature and represents my own independent opinion.
The Act is a welcome change to the old regime where national provisions concerning the subject matter have been scattered into different regulations, namely the Patient’s Rights Act (1992/785), Act on Electronic Processing of Social and Health Care Customer Data (2007/159), Bio Bank Act (2012/688) and Medicines Act (1987/395).
In this products liability case against pharmaceutical manufacturers, the plaintiffs’ used an internal BMS email and PowerPoint during the January 31, 2018, deposition of BMS’ executive director for Abilify marketing from February 2007-December 2008. Case Background.
Given the increasing importance of safe but swift clinical trials in the time of coronavirus, this post outlines the main changes introduced from a data protection perspective and what they mean for contracting parties.
We organize all of the trending information in your field so you don't have to. Join 55,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content